Abstract
Objectives: The aim of this review was to analyze the role of follow-up in patients treated for endometrial cancer and to provide some compelling issues that may contribute to improve daily practice while waiting for evidence-based guidelines. Methods/Materials: A literature search has been conducted in MEDLINE database using key words "endometrial neoplasms" and "follow up". Results: Endometrial cancer represents the most common gynecologic malignancy after breast cancer. The overall recurrence rate is 13% and correlates with prognostic factors of the primary tumor. The anatomic sites of endometrial cancer relapse are mostly equivalently distributed between local (pelvic) and distant (abdominal and chest). Most endometrial cancer recurrences are symptomatic, even if vaginal vault relapses represent a particular setting of a more frequently asymptomatic disease. Most of endometrial cancer recurrences occur within 3 years since diagnosis of primary tumor. Long-term surveillance programs are mainly addressed to the early detection of recurrence, the rationale of follow-up being that an earlier diagnosis of relapse correlates with lower morbidity and mortality rates. Adjunctive objectives of routine follow-up are identification of treatment complications and detection of possible second tumors associated with endometrial cancer. Conclusions: No rationale (examination sensitivity/sensibility, cost-effectiveness, or patient's survival benefit) is available today for any particular follow-up protocol; follow-up procedures should probably be tailored according to different prognostic factors; only physical examination, including pelvic-rectal examination, showed some utility in detecting recurrence. In this uncertain setting, follow-up interval should be defined with the consideration of the patient's will.
| Original language | English |
|---|---|
| Pages (from-to) | 985-992 |
| Number of pages | 8 |
| Journal | International Journal of Gynecological Cancer |
| Volume | 20 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Aug 2010 |
Fingerprint
Keywords
- Endometrial Cancer
- Follow-up
- Procedures
ASJC Scopus subject areas
- Obstetrics and Gynaecology
- Oncology
- Medicine(all)
Cite this
Surveillance procedures for patients treated for endometrial cancer : A review of the literature. / Sartori, Enrico; Pasinetti, Brunella; Chiudinelli, Francesca; Gadducci, Angiolo; Landoni, Fabio; Maggino, Tiziano; Piovano, Elisa; Zola, Paolo.
In: International Journal of Gynecological Cancer, Vol. 20, No. 6, 08.2010, p. 985-992.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Surveillance procedures for patients treated for endometrial cancer
T2 - A review of the literature
AU - Sartori, Enrico
AU - Pasinetti, Brunella
AU - Chiudinelli, Francesca
AU - Gadducci, Angiolo
AU - Landoni, Fabio
AU - Maggino, Tiziano
AU - Piovano, Elisa
AU - Zola, Paolo
PY - 2010/8
Y1 - 2010/8
N2 - Objectives: The aim of this review was to analyze the role of follow-up in patients treated for endometrial cancer and to provide some compelling issues that may contribute to improve daily practice while waiting for evidence-based guidelines. Methods/Materials: A literature search has been conducted in MEDLINE database using key words "endometrial neoplasms" and "follow up". Results: Endometrial cancer represents the most common gynecologic malignancy after breast cancer. The overall recurrence rate is 13% and correlates with prognostic factors of the primary tumor. The anatomic sites of endometrial cancer relapse are mostly equivalently distributed between local (pelvic) and distant (abdominal and chest). Most endometrial cancer recurrences are symptomatic, even if vaginal vault relapses represent a particular setting of a more frequently asymptomatic disease. Most of endometrial cancer recurrences occur within 3 years since diagnosis of primary tumor. Long-term surveillance programs are mainly addressed to the early detection of recurrence, the rationale of follow-up being that an earlier diagnosis of relapse correlates with lower morbidity and mortality rates. Adjunctive objectives of routine follow-up are identification of treatment complications and detection of possible second tumors associated with endometrial cancer. Conclusions: No rationale (examination sensitivity/sensibility, cost-effectiveness, or patient's survival benefit) is available today for any particular follow-up protocol; follow-up procedures should probably be tailored according to different prognostic factors; only physical examination, including pelvic-rectal examination, showed some utility in detecting recurrence. In this uncertain setting, follow-up interval should be defined with the consideration of the patient's will.
AB - Objectives: The aim of this review was to analyze the role of follow-up in patients treated for endometrial cancer and to provide some compelling issues that may contribute to improve daily practice while waiting for evidence-based guidelines. Methods/Materials: A literature search has been conducted in MEDLINE database using key words "endometrial neoplasms" and "follow up". Results: Endometrial cancer represents the most common gynecologic malignancy after breast cancer. The overall recurrence rate is 13% and correlates with prognostic factors of the primary tumor. The anatomic sites of endometrial cancer relapse are mostly equivalently distributed between local (pelvic) and distant (abdominal and chest). Most endometrial cancer recurrences are symptomatic, even if vaginal vault relapses represent a particular setting of a more frequently asymptomatic disease. Most of endometrial cancer recurrences occur within 3 years since diagnosis of primary tumor. Long-term surveillance programs are mainly addressed to the early detection of recurrence, the rationale of follow-up being that an earlier diagnosis of relapse correlates with lower morbidity and mortality rates. Adjunctive objectives of routine follow-up are identification of treatment complications and detection of possible second tumors associated with endometrial cancer. Conclusions: No rationale (examination sensitivity/sensibility, cost-effectiveness, or patient's survival benefit) is available today for any particular follow-up protocol; follow-up procedures should probably be tailored according to different prognostic factors; only physical examination, including pelvic-rectal examination, showed some utility in detecting recurrence. In this uncertain setting, follow-up interval should be defined with the consideration of the patient's will.
KW - Endometrial Cancer
KW - Follow-up
KW - Procedures
UR - http://www.scopus.com/inward/record.url?scp=77956829833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77956829833&partnerID=8YFLogxK
U2 - 10.1111/IGC.0b013e3181e2abcc
DO - 10.1111/IGC.0b013e3181e2abcc
M3 - Article
C2 - 20683406
AN - SCOPUS:77956829833
VL - 20
SP - 985
EP - 992
JO - International Journal of Gynecological Cancer
JF - International Journal of Gynecological Cancer
SN - 1048-891X
IS - 6
ER -